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Abstract
KEITH BORG. Involvement of Human Immunodeficiency Virus Type-l
Splice Sites in the Cytoplasmic Accumulation of Viral RNA. (Under the
direction of SALVATORE ARRIGO).
The Human Immunodeficiency Virus Type 1 is a complex retrovirus,
which produces a large number of proteins from a 10 Kb genome. The
virus utilizes three overlapping open reading frames, a ribosomal
frameshift event and three different classes of RNA (unspliced, partially
spliced and fully spliced RNA) to perform this feat. To regulate the
expression of these RNAs, HIV-l requires Rev, a viral trans regulatory
protein. The fully spliced RNAs are not dependent upon Rev for their
expression. The unspliced and partially spliced RNAs are dependent on
Rev to produce proteins. Rev binds to the Rev Response Element (RRE)
located in the Rev dependent RNAs. The sequences responsible for the
lack of production of protein in the absence of Rev, have been termed Cisacting Repressor Sequences (CRS). Little is known about the mechanism
or nature of CRS. It is believed that CRS serve to confer Rev dependence
on the RNA and allow for the regulation of the RNA at a number of posttranscriptional levels. It is our hypothesis that, since Rev regulates the
production of the different classes of mRNA, splice sites are intimately
involved in the regulation of these RNAs by Rev. To define the role of
Human Immunodeficiency Virus type 1 splice sites in the cytoplasmic
accumulation of viral RNAs, sequential deletion mutagenesis on an
infectious proviral clone of HIV-l was performed. Deletion of the majority
of intron sequences, containing previously identified CRS, did not
attenuate CRS activity. Retention of either the first or second tat intron

..

VII

preserved CRS activity. RNAs containing splice donor sequences, in the
absence of known downstream splice acceptor sequences, retained CRS
activity. These results indicate that the major HIV-l splice donors can
function as CRS and function to negatively regulate the cytoplasmic
accumulation of HIV-l RNAs in COS cells. In order to further analyze the
role of a splice donor in Rev dependence, the wild type 5' splice donor of
HIV-l was mutated in the context of other gag sequences. The unspliced
RNA produced by the mutant construct still required Rev for the
cytoplasmic accumulation of the RNA. Despite deletion of the wild type 5'
splice donor, splicing still occurred, as measured by usage of the tat splice
acceptor. A cryptic splice donor was identified by PCR and subsequent
cloning of the spliced RNA. The cryptic site is 5/9 to the consensus
sequence and located immediately downstream of the initiation codon
(ATG) for Gag. Analysis of RNA containing the cryptic splice donor
demonstrated that Rev is still required for the cytoplasmic accumulation
of the unspliced RNA, while spliced RNA is Rev independent. These
results indicate that a cryptic splice donor can be activated when the wildtype splice donor is inactivated and that the cryptic splice donor retains
Rev regulation. The findings also suggest the potential for cryptic splice
sites to serve as CRS in determining the Rev-dependence of viral RNAs.
These studies have investigated the critical role that splice sites can play
in viral gene regulation and shown that splice sites, both wild-type and
cryptic can function as CRS to control viral RNA expression.
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Chapter 1

General Introduction

2

The complex gene regulation mechanisms of cells are utilized by
viruses to regulate and facilitate programs of viral gene expression. To
understand the coordinating mechanisms of viral gene regulation, it is
crucial to understand the cellular processes involved in RNA processing in
concert with gene expression. Eukaryotic processing of mRNA is a
complex process that begins in the nucleus following transcription. An
outline of the steps involved in RNA processing is depicted in Figure 1-1.
Immediately following transcription, or even as it occurs, proteins called
snRNPs (small nuclear ribonucleoproteins) associate with this primary
transcript. snRNPs serve many functions during the processing of the
transcript. The Ul, U2, U5 and U4/6 snRNPs are involved in formation of
the catalytic spliceosome which serves to splice the pre-mRNA (see figure
1.2) (Alberts et al., 1994)
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Transcription of Primary Transcript

•

hnRNA Transcript Bind snRNPs

Capping and Polyadenylation of RNA

Splicing of mRNA

Export of mRNA to Cytoplasm

Translation

Figure 1.1 RNA Expression Steps involved in RNA processing in the
nucleus and subsequent export from the nucleus to the cytoplasm.
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After transcription and snRNP binding, the RNA is covalently
modified at the 5' and 3' ends of the primary transcript. The 5' end is
capped with a 7-methyl Guanosine residue; which is important not only in
protecting the RNA from degradation, but also in the initiation of
translation. The 3' end of the primary transcript is polyadenylated by
poly-A polymerase which adds a series of adenosine residues about 20bp
downstream of the polyadenylation signal- AAUAAA (Alberts et at., 1994).
This poly-A tail serves several functions in RNA processing including
stabilization of the RNA and initiation of 60s ribosomal subunit binding
for protein synthesis (Sachs and Wahle, 1993; Sachs, Bond, and Kornberg,
1986; Sachs and Davis, 1989; Sachs and Deardorff, 1992).
After initial processing the RNA is spliced via two transesterification reactions to produce a spliced product. This process takes
place when snRNPs bound to the RNA catalyze the cleavage and ligation
of the two exons and removal of the intron (Moore, Query, and Sharp,
1993). This multistep process is depicted in Figure 1.2. There are several
critical sequences involved in the splicing pathway. At the 5' end of the
intron there is a splice donor sequence which binds the Ul snRNP. At the
3' end of the intron, the branch point sequence binds U2. There are two
other important 3' sequences, the splice acceptor site and the
polypyrimidine tract which are involved in the selection of the splice
acceptor. UI and U2 then bind the U4/6 and U5 snRNPs which complex to
form the spliceosome, the functional unit which removes introns from the
primary transcript to produce a spliced RNA product (Adams, Rudner, and
Rio, 1996; Moore, Query, and Sharp, 1993). This final product is then
exported from the nucleus to the cytoplasm.
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Figure 1.2 Splicing Pathway The process of splicing is shown with the
various snRNPs binding to the primary RNA transcript followed by lariat
formation, splice site cleavage and exon ligation the RNA to remove
intronic sequences (Adapted from Moore by Justin Favaro) (Moore, Query,
and Sharp, 1993).

The normal process of eukaryotic RNA splicing is inherently
different from that of the splicing of retroviral transcripts. This is because
of the fact that retroviral primary transcripts are multiply and variably
spliced to produce different viral mRNAs. (see Figure 1.3 and 1.5). The
primary transcript itself also encodes structural proteins as well as
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functioning as the genomic RNA for progeny virions and is exported
unspliced into the cytoplasm of the cell. This is in contrast to unspliced
cellular RNAs, which are not found in the cytoplasm. This incomplete
splicing is an important step in the regulation because it provides the
temporal switch between production of early viral regulatory proteins
from completely spliced RNAs, to the production of structural proteins
from unspliced and incompletely spliced RNAs (Arrigo and Beemon, 1988;
Katz, 1990; O'Reilly, McNally, and Beemon, 1995). This critical
mechanism of regulation is poorly understood. However, cis-acting
mechanisms of splicing regulation have been examined. cis-acting
elements have been described in retroviruses that downregulate splicing.
Examples described include a negative regulator of splicing (nrs)
identified in Rous sarcoma virus (Arrigo and Beemon, 1988). HIV-1 also
has cis elements in env that downregulate splicing of the second intronic
region (Amendt, Si, and Stoltzfus, 1995). These elements combine with the
suboptimal consensus sequence of splice sites and decrease the efficiency
of a normally efficient process. The decrease in efficiency of splicing is
critical to the ability to regulate this process.
After splicing, the cellular RNA is exported to the cytoplasm. Export
of RNA is a regulated event that involves a series of steps that involve the
binding of a number of cellular factors to facilitate transport across the
nuclear membrane. The mechanisms of RNA export are currently a very
active area of investigation as is the study of much of the regulation
involving nuclear and cytoplasmic trafficking (Ullman, Powers, and
Forbes, 1997). Elucidation of the mechanisms of transport and possible
regulatory steps involved in the process will aid the understanding of the
role of export in retroviral gene expression.

7

RNA metabolism is also regulated in the cytoplasm via interactions
that regulate the stability and translational processing of the RNA. This
is a brief description of the complex pathway of RNA processing. The
importance of understanding the pathways of RNA processing can not be
overemphasized. It is only through understanding the temporal
processing of RNA that the possible regulation of those steps can be
investigated. For now, a basic understanding of cellular RNA processing
will allow. the exploration of the gene regulation and the life cycle of a
complex retrovirus.
The Human Immunodeficency Virus Type 1 (HIV-l) is a retrovirus
which is the etiologic agent of the Acquired Immune Deficiency Syndrome
(AIDS). (for review see Levy93) It is a member of the lentivirus genus of
retroviruses. In a 10 kb genome, HIV-1 possesses at least 9 genes (Figure
1.3). These genes include gag, pol, and env common to all retroviruses.
HIV-l also has several regulatory genes- tat ,rev and net. Other accessory
regulatory genes include vif, vpr, vpu and nef The gag gene encodes viral
structural proteins. Translation of gag results in a polyprotein, which is
subsequently cleaved by the viral protease into the component proteinsmatrix, capsid and nucleocapsid. Pol encodes the viral enzymes (reverse
transcriptase, integrase, RNase H and protease).

Env encodes the

envelope proteins of the virus (gp120 and gp41). gp120 is inserted into the
cell membrane and thereby incorporated into virions during budding. In
infection gp120 functions as a ligand for the CD4 receptor which along
with a chemokine receptor, facilitates the binding of the virion to the cell.
The fusion of the viral envelope to the cell during infection is facilitated by
the action of gp41. vir is involved in the infectivity of the virus. vpr plays
a role in the pathogenesis of the virus during infection. vpu plays a role in
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virus assembly. Nef, a regulatory protein produced from a fully spliced
RNA, has two major functions in the viral life cycle; including the
downregulation of CD4 receptors and involvement in viral pathogenesis
during infection.
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Figure 1.3 HIV-1 Genome and RNAs. The HIV-1 Genome and RNAs
produced by the virus. The genome of HIV-1 is depicted along with the
various RNAs produced through differential splicing of the full length
RNA. Rev dependence and the presence of CRS are noted.

HIV-1 expresses at least 17 proteins from a 9.6kb genome. In order
to do this; the virus utilizes the mechanisms outlined previously, which
include the production of three different classes of RNA. These are
produced through various combinations of the major splice donors and
splice acceptors. These RNAs and their protein products are depicted at
the bottom of Figure 1.3 along with the splicing events required for their
formation.
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The gene expression of HIV-l is coordinated by the products of tat
and rev. They share some common features. Both function in trans and
are produced as early proteins produced from a fully spliced mRNA.
Following translation both localize to the nucleus and bind target sites on
RNA. After binding, tat and rev exert their effects on the RNA. Tat binds
to the TAR element of the RNA and functions to increase transcription
from the viral LTR. Tat serves primarily to increase the efficiency of
elongation, but also may affect initiation of transcription (for review see
Cullen95). It provides the "on" switch to begin the process of viral gene
expression. Expression of HIV-1 genes is further controlled by Rev. Rev is
a 19kd trans regulatory protein that is required for expression of viral
structural proteins (Malim et al., 1988; Malim et al., 1989b; Sodroski et al.,
1986).

The mechanism of Rev function is poorly understood. Many

studies have found Rev to playa pivotal role at a number of points in viral
gene expression. These points are the splicing, transport, stability and
translation of mRNA. Rev binds to its recognition sequence, the Revresponse element (RRE), located in env (see Figure 1.3). Rev can be divided
into two functional regions (Figure 1.4). The N-terminal region binds to
the RRE as well as containing a nuclear localization signal. This region
consists of a series of arginine residues (Berger et al., 1991; Malim et al.,
1989a). Overlapping this domain is the multimerization region. Rev binds
to the RNA as a monomer but subsequently multimerizes to achieve its
effects (Olsen et al., 1990). The C-terminal region of the protein contains
an effector domain consisting of a series of leucines (Berger et al., 1991;
Malim et al., 1989a). Mutations in this region abolish function of the
protein but produce trans dominant molecules. These trans dominants are
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capable of binding to the RRE and inhibit the function of wild type Rev
(Arrigo, Heaphy, and Haines, 1992; Garrett and Cullen, 1992).
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N

Multi RBD Multi

Effector

C

Figure 1.4 Structural Domains of Rev. The functional regions of the Rev
protein are indicated in the above diagram. The multimerization domain
overlaps the RRE binding domain near the N-terminal of the protein.

The RRE serves as a Rev binding site on the RNA. The RRE is a 234
nucleotide stem-loop structure normally located in env (Hadzopoulou et al.,
1989; Malim et al., 1989b; Rosen et al., 1988). It is present in unspliced and
partially spliced RNAs but is removed from the fully spliced RNAs (see
Figure 1.3). The location of the RRE, within the RNA, is not important; as
intronic sites appear to function as well as exonic sites for Rev function
(Campbell, Borg, and Arrigo, 1996; Malim et al., 1989b). However, the
effect of the RRE is orientation dependent (Hammarskjold et al., 1989). The
structure of the RRE is a complex folded RNA that has specific structural
components. One of these is the high affinity binding site for Rev that has
been ascribed to the lIb region of the element. Other regions and sequence
are important in multimerization and further binding of Rev to the RRE
(I\jems et al., 1991; Mann et al., 1994). Following binding of Rev to the
region it can then exert its effects on the fate of the RNA.
Several theoretical mechanisms for Rev function have been
proposed and tested. One is that Rev serves to enhance transport of the
Rev-dependent RNAs, rescuing them from being trapped in the nucleus.
This mechanism argues that Rev functions by binding to the RNA and
then facilitating its transport from the nucleus to the cytoplasm.
Experiments with Rev fused to BSA have shown functional export of the
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proteins from the nuclei of Xenopus (Fischer et al., 1994). One piece of data
absent in this mechanism was the identification of the cellular cofactors
required for Rev to function in this manner. This factor has now been
identified by several groups as a nucleoporin-like protein.

Rev associates

with this nucleoporin-like protein, which theoretically enables transport
of the Rev bound RNA. This factor was identified using the yeast twohybrid system and contains similar motifs to nucleoporins, which are
components of the nucleopore complex (Bogerd et al., 1995; Fritz, Zapp, and
Green, 1995; Stutz, Neville, and Rosbash, 1995). Consequently, this
protein may function as a cellular cofactor for Rev to facilitate export of
bound RNAs. However, additional work is required in order to establish a
clear relationship between Rev, the nucleoporin-like protein and the
mRNA.
Several lines of evidence suggest that Rev may directly affect
splicing of HIV-1 RNAs in order to regulate production of the various
species of HIV-1 RNA. An inhibition of splicing in vitro was demonstrated
using a peptide containing the Rev RNA binding domain (Kjems, Frankel,
and Sharp, 1991). This inhibition of splicing was not seen in vivo;
therefore it is difficult to evaluate the relevance of this data. While
certainly an attractive theory for Rev function, there is little evidence that
Rev directly inhibits splicing to increase the production of unspliced and
partially spliced RNA. It may be that the shift in production of RNAs is
the result of changes in export, which indirectly change the levels of RNA
or some combination of these effects.
Several studies have shown effects of Rev on translation of RNA.
They have demonstrated a translational effect, in that in the absence of
Rev, RNAs can accumulate in the cytoplasm, but are not translated.
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Several groups have shown these effects in lymphoid cells (Arrigo and
Chen, 1991) and fibroblast cells (D'Agostino et al., 1992). The partially
spliced messages accumulated in the cytoplasm, but were not translated.
When examined by sucrose gradients, these untranslated RNAs were
deficient in polysome formation. The fact that these RNAs could be
translated in vitro strongly indicates a translational regulatory function
for Rev. In the absence of Rev; Poly-A Binding Protein (PAB1) was not
associated with the Rev-dependent messages. PABI binding has been
shown to be critical for the association of the 60S ribosomal subunit and
translation. At what stage Rev binding affects the association of PAB1 is
unclear, but the failure to associate with PABI might be indicative of
translational regulation of HIV-1 mRNAs by Rev.
A possible cofactor for Rev, eIF-5A, may shed light on a mechanism
of translational regulation. Initial studies reported the interaction
between Rev and elF -5A. These studies were performed by crosslinking
the proteins (Ruhl et al., 1993). Additional studies using transdominant
eIF-5A proteins have also suggested an interaction with Rev (Katahira et
al., 1995). This research is hampered by a lack of understanding of the
function of eIF-5A. Without a clear understanding of the cellular role of
eIF-5A, the importance of the data is difficult to estimate.

While the level

at which Rev functions and its various cellular cofactors are complex and
poorly understood, the viral requirement for Rev remains absolute.
The answer to the question of why Rev is required for the expression
of the Rev-dependent RNAs may lie in a series of ill-defined sequences
known as Cis-acting Repressor Sequences (CRS). These sequences, in the
absence of Rev, have a negative effect on the RNA and prevent its
cytoplasmic accumulation. CRS are RNA sequences that are defined
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functionally. When present in RNA, eRS negatively regulate the
expression of the RNA. The second criterion required for definition as a
CRS is that Rev must be able to rescue the RNA from this negative

regulation through binding to the RRE. Two major groups of sequences
have been implicated as eRS 1) sequences in gag, pol and env (intronic
CRS) and 2) splice sites (see Figure1.3 and 1.5).

Several groups have worked to identify a series of eRS elements
that are located in the gag, pol and env coding regions of the virus (Rosen

et al., 1988). These eRS have several factors in common. They are large
(200+bp), function in the sense orientation, have no obvious sequence
homology and require a large number of mutations to delete their negative
function. The eRS located in gag is perhaps one of the best studied of this
type. It is located in the p17 region and required 28 point mutations in the
270 bp element to inactivate. The inactivation of this eRS allowed for the
discovery of another in the gag-pol region (Schwartz, Felber, and Pavlakis,
1992a). Other groups have also noted eRS in pol which appear similar to
the eRS described in gag. The eRS is 260bp in size, located 3' in pol and
was defined by deletion mutagenesis (Cochrane et al., 1991). The nature of
this element appears similar to that described for the gag CRS. The
duplicative nature of these elements is certainly interesting. Why is there
a need for so much redundancy in negatively regulating early expression
of structural proteins? This question is largely unanswered.
Multiple elements in env have been described as CRS. These
elements appear similar to those described in gag (Nasioulas et al., 1994).
After inactivation of an env eRS, other eRS were identified in env. This
observation is similar to the identification of multiple elements in the gagcoding region. Several groups have reported that the RRE functions as a
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CRS (Brighty and Rosenberg, 1994; Nasioulas et al., 1994). This effect of
the RRE is not seen in all systems, consequently the RRE may function as
a CRS in only certain contexts. Studies of intronic CRS have not
discovered a mechanism of function for the negative regulation of Rev
dependent RNAs. Decreased stability, blocked export and translational
inhibition have all been suggested as possible mechanisms for regulation
of RNAs containing CRS.
The second major class of identified CRS elements is splice sites.
These have been identified in several different systems as negatively
regulating RNA expression. The addition of HIV-1 splice donors and
acceptors to heterologous constructs induces Rev dependence (Chang and
Sharp, 1989). The splice donors of HIV-1 are fairly good matches to the
consensus sequence identified for splice sites (Mount, 1982). The splice
acceptors are notably poor in HIV-1 and several groups have reported that
suboptimal splicing events are necessary for Rev-responsiveness of the
RNA (O'Reilly, McNally, and Beemon, 1995). Other groups have noted
CRS effects of splice donors when placed in the 3' UTR of papillomavirus
constructs (Barksdale and Baker, 1995) and of the 5' splice donor of Equine
Infectious Anemia Virus (Tan et al., 1996). The major 3' splice donor has
been the subject of previous investigation and mediates the Rev
dependence of env constructs. When the splice donor is mutated and an
excisable intron was placed upstream, env expression became Rev
independent (Hammarskjold et al., 1994). These studies indicate that
splice donors can function as CRS and that the splicing event must be
suboptimal in order to be regulated by Rev. The mechanisms of CRS
function and Rev rescue of Rev dependent RNA are still largely unknown.
Some groups have suggested instability, impaired nuclear export or

16
translational effects as the means by which RNAs are negatively
regulated in the absence of Rev, but these data are far from conclusive
(Dayton, 1996).
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Figure 1.5 Splice Sites of HIV-1
The major splice sites of HIV-1 are depicted. Splice donors are shown as
black triangles and splice acceptors as white triangles. These sites are
used in combination to produce the viral RNAs.
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CRS facilitate the regulation of HIV-l mRNA by Rev. However, the
molecular mechanisms of this regulation remain undefined. In order to
begin to explore the role of CRS function, it is critical to dissect apart the
Rev-RRE axis of expression so those individual components can be
examined for their function in HIV-l gene regulation. Consequently, it is
critically important that transcription, splicing, export, stability and
translation be considered as possible control points of CRS function. In
examining the various steps of this axis of expression, we can begin to
tease apart complex relationships between the components in order to
better understand the gene expression of HIV-l.
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Chapter 2

Involvement of Human Immunodeficiency
Type-1 Splice Sites in the Cytoplasmic Accumulation
of Viral RNA
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In trod uction
Splice sites are important elements involved in the Revresponsiveness of HIV-1 mRNAs. This is true for several reasons. One is
the variation in patterns of RNA produced in the presence and absence of
Rev. Rev mediates the shift from the production of fully spliced RNA to the
production of predominantly unspliced and partially spliced RNAs. The
fact that splice donors can function as CRS also implicates splice site
involvement in the Rev responsiveness of RNAs. By negatively regulating
the RNA, splice donors serve as sequences (or at least some of the
sequences) that establish the viral requirement for Rev. In order to
explore this activity, we first wish to isolate splice sites to examine their
role as regulatory elements involved in the cytoplasmic accumulation of
HIV-1 mRNAs. A series of experiments with isolated splice sites will serve
to characterize the function of these elements in HIV-1 gene expression.
The constructs used to examine splice site function will contain deletions
for known intronic CRS so that isolated splice donors and splice acceptors
can be examined to determine their role in Rev responsiveness of HIV-1
mRNA.
The expression of HIV-1 structural proteins is regulated at the level of
splicing, transport, stability, and translation by the Rev protein (Arrigo
and Chen, 1991; Cochrane et al., 1991; DtAgostino et al., 1992; Feinberg et

al., 1986; Felber et al., 1989; Hadzopoulou et al., 1989; Hammarskjold et al.,
1989; Lawrence et al., 1991; Malim et al., 1988; Schwartz, Felber, and
Pavlakis, 1992a; Sodroski et al., 1986). The Rev protein binds to an RNA
binding site termed the Rev-responsive element (RRE) present within the
RNAs that it regulates (Hadzopoulou et al., 1989; Malim et al., 1989b;
Rosen et al., 1988). This regulation may involve alteration of the cellular
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pathway of the RNA (Fischer et al., 1995). The Rev-dependent RNAs
require Rev for protein expression and therefore must contain negative
sequences, the effect of which is overcome by the Rev protein (for review
see Dayton 1996). The Rev-independent tat, rev, and nef genes presumably
do not contain these sequences. These negative sequences have been
termed cis-acting repressor sequences, CRS, and have been characterized
in a variety of experimental systems. Splice sites have been implicated in
Rev regulation by several groups. Introduction of sequences containing
the HIV-1 tat 3 1 splice donor or splice acceptor sequences (i.e., those splice
sites that join the Tat coding exons) into a construct containing a B-globin
intron conferred Rev-responsiveness to the construct (Chang and Sharp,
1989). Rev-responsiveness could also be conferred by mutation of the Bglobin splice site consensus sequence within this construct. The CRS
potential of splice donor sequences has been demonstrated by the Revresponsiveness of papillomavirus constructs containing a splice donor in
the 3 1 untranslated region (Barksdale and Baker, 1995). The major 51
splice donor of equine infectious anemia virus functions as a CRS within
EIAV Gag-producing constructs, although it functions in a locationdependent manner (Tan et al., 1996). Within HIV-1 Env-expressing
constructs, splice sites and V1 interaction have been shown to be
important for the regulation of Env expression by Rev (Lu et al., 1990).
Furthermore, the expression of Env could be made Rev-independent by
placing a complete intron upstream of env and removing known splice
donor sequences (Hammarskjold et al., 1994).
Other sequences within HIV-1, distinct from splice sites, have also
been shown to exhibit CRS activity. The fusion of various fragments of the
gag, pol, and env genes to a CAT reporter construct resulted in Rev-
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responsiveness (Cochrane et al., 1991; Rosen et al., 1988). The CRS within
pol elicited an orientation-dependent 30-fold negative effect on CAT

activity that could be rescued by Rev and the RRE. This CRS is located
within HIV-l sequences that are not known to contain any splice sites.
The effect appeared to be at the mRNA utilization level in that the
subcellular distribution of RNA was not substantially affected. Fusion of
regions of both gag and pol to reporter constructs also demonstrated at
least two orientation-dependent eRS that functioned
posttranscriptionally (Maldarelli, Martin, and Strebel, 1991). These
sequences do not contain known splice sites and were not substantially
affected by the addition of splice sites to the constructs. Fusions of gag to a

tat-expression vector were used to analyze eRS activity within gag
(Schwartz, Felber, and Pavlakis, 1992a). A less than 300 base pair
fragment of gag was capable of exerting an effect on the total RNA
production, which was attributed to differences in RNA stability.
Mutational inactivation of this CRS required 28 point mutations,
demonstrating the complex nature of this eRS (Schwartz et al., 1992). In
the absence of known splice sites, env expression was shown to be Revdependent in mammalian cells using Env expression vectors (Nasioulas et

al., 1994). Localization of eRS within env identified many regions capable
of exerting modest negative activity, which together exerted activity that
is more dramatic. Deletion of the RRE led to Rev-independent expression
of Env from subgenomic env constructs, indicating that a eRS may
overlap RRE sequences (Brighty and Rosenberg, 1994; Churchill et al.,
1996). The complexity of the interaction between the gag eRS and splicing
was recently demonstrated (Mikaelian et al., 1996). The gag eRS in
conjunction with the RRE was capable of conferring Rev-responsiveness
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on a B-globin construct. Mutations in splice sites rendered these
constructs Rev-independent. Therefore, it appears that CRS may function
at a variety of levels to decrease the expression of RNAs containing these
elements.
In this chapter, we investigated the involvement of HIV-l splice
sites in Rev regulation through sequential mutagenesis of an infectious
proviral clone. In order to avoid the complexities of analyzing multiple
types of CRS, the majority of intronic sequences were deleted, retaining
the splice sites necessary for the production of the multiply spliced RNAs.
Analysis of the ratio of cytoplasmic to nuclear HIV-l RNAs, in the
presence or absence of Rev or the RRE, using these constructs served as
an indicator of CRS activity.
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Materials and Methods

Plasmid Constructions
The BI construct was constructed from pYKJRCSFIEBV- (Arrigo
and Chen, 1991) using DR mutagenesis (Gatlin et al., 1995). gag, pol, vit
and part of vpr were deleted (nt790-5710), leaving the major splice donor
and Gag methionine intact. env and vpu were removed by deleting from
just downstream of the 3' splice donor for tat, rev, and net to just upstream
of the most 3' splice acceptor (nt6145-8307). The BI construct retains the
splice sites for the generation of tat, and is deleted for the majority of tat
intronic sequences. The BIR construct was generated by insertion of an
RRE-containing SalI fragment into the XhoI site within the net sequences
of the BI construct (Campbell, Borg, and Arrigo, 1996). FI and FIR
constructs were generated using DR mutagenesis. The second tat/rev
intron was deleted in frame from the BI and BIR constructs using the
following oligonucleotide primers: 5'TGCTTTGGTAGAGAAACTTGATGAGTCTGAC-3' and 5'ACCCTCCTCCCAGCAACGAG-3'. This deletion creates an in-frame
fusion of the two tat coding exons. SI and SIR constructs were generated
using DR mutagenesis. The first tat intron was deleted from BI and BIR
constructs using the following oligonucleotide primers: 5'CAGTCGCCGCCCCTCGCCTC-3' and 5'_
AATTGGGTGTCGACATAGCAGAATAGGC-3' .
The SD2R construct was generated by restriction digestion of the SIR
construct with BamHI and religation. The SDI construct was generated
using PCR and contains sequences from nt153-793, and nt9036-9736 from
pYKJRCSF, including the sequences encompassing the major 5' HIV-l
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splice donor. These sequences were cloned into pGem2 (Promega). The
SD1R construct was generated by insertion of the RRE-containing SpeI
fragment (Campbell, Borg, and Arrigo, 1996) into the SD1 construct. The
NI construct was generated by the cloning of a PCR fragment into the SD1
construct. A 160 bp fragment was amplified using the BI construct as a
template and the oligonucleotide primers: 5'ACAACCATGGAGGCTAGCTAGGGAACCCACTG-3' and 5'AACAGAATTCTCGCTTTCCGGTCCCTGTTC-3'. PCR conditions were as
previously described (Arrigo, Heaphy, and Haines, 1992). The PCR
product and the SD1 construct were digested with NcoI and EcoRI. The
PCR product was inserted into the SD1 construct to generate NI using
standard molecular techniques. The NI construct contains a deletion of
almost all sequences between the splice donor and the polyadenylation
signal, retaining 78 base pairs between these two elements. L1NI was
generated from the NI construct using DR mutagenesis and the following
oligonucleotide primers: L1SD1, 5'_
AGAACCGCGGACGCCGAAATTTTGACTAGCGGAGGC-3' and L1SD1A,
5'-ACTACCGCGGGTCGCCGCCCCTCGCCTCTTGC-3'. This results in
the deletion of the consensus splice donor site, TGGTGAGT, from the NI
construct and the insertion of the sequence CCGCGG.

Cell Culture and Transfection
COS cells were maintained in Iscove's medium supplemented with
10% fetal calf serum. Transfections were performed as described
previously (Arrigo et al., 1989). A total of 50 Jlg of plasmid DNA was
electroporated for each sample. Cotransfections were performed with the
indicated construct without or without the addition of pSVtat and/or
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pCMV Rev (Lewis et ai., 1990). A filler construct (pcDNA3, Invitrogen)
was used to normalize the total amount of DNA to 50Jlg. A confluent
T175cm 2 flask of cells was used for approximately six transfections. RNA
was harvested approximately 40 hours post-electroporation.

RNA fractionation and analysis
Cells were fractionated as previously described (Favaro and Arrigo,
1997). Isolation of RNA and RT-PCR was performed as previously
described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et al., 1990).
RT-PCR was performed for 20 cycles of amplification for all RNAs except
that of the total RNA produced by NI and ilNI which was amplified for 15
cycles. Most of the oligonucleotide primers used for detection have been
previously described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et
al., 1990). The unspliced RNAs produced by the BIIBIR, FIIFIR, SDI/SDIR,

and NIIilNI constructs was detected with the LA8/Gag-Nco oligonucleotide
primers. The unspliced RNAs produced by the SIISIR and SD2/SD2R
constructs were detected with the LA45/AA821 oligonucleotide primers.
The spliced RNAs produced by the BIIBIR and SIISIR constructs were
detected with the LA45ILA41 oligonucleotide primers. The spliced RNAs
produced by the FIIFIR constructs were detected with the LA8ILA23
oligonucleotide primers. Oligonucleotide primers LA23 (5'GCCTATTCTGCTATGTCGACACCC-3'; nt5815-5792) and Gag-Nco (5'CGCACCCATGGCTCTCCTTCTAG-3'; nt797-775) are antisense primers
homologous to sequences downstream of the most 5' tat splice acceptor and
major 5' splice donor, respectively. Total RNA produced by the SDIR,
SD2R, and NIILlNI constructs was detected with an oligonucleotide pair
located upstream of the major 5' splice donor: LDR1 (5'_
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GAACAGGGACCGGAAAGCG-3'; nt644-662) and a-LDRI (5'GC GC GCTTCAGCAAGC CGAG-3 '; nt716-697).
Quantitation of the ratio of cytoplasmic to nuclear RNA was
performed by scanning autoradiographs with a Lacie DTP Silverscan III
scanner. Individual bands were quantitated with NIH Image 1.59.
Analysis was performed on a Macintosh 7100/80 computer using the
public domain NIH Image program (developed at the U.S. National
Institutes of Health and available from the Internet by anonymous FTP
from zippy.nimh.nih.gov or on floppy disk from the National Technical
Information Service, Springfield, Virginia, part number PB95500195GEI). The cytoplasmic fractions (Cyto 1 and Cyto 2) were added
together and compared to the nuclear fraction to determine the ratio of
cytoplasmic to nuclear RNA. The level of nuclear RNA was arbitrarily set
to a level of 1.

Results

Deletion of the majority of intronic sequences from HIV·l does
not eliminate eRS activity.
CRS activity has been attributed to intronic sequences within gag,
pol and env. Starting with an infectious clone of HIV-l, the majority of

intronic sequences were deleted. These deletions remove most of the
sequences known to contain CRS activity. The resultant construct, BI,
retains minimal amounts of both HIV-l tat introns (Fig. 2.1). The BI
construct retains 145 nucleotides of 5' and 150 nucleotides of 3' intronic
sequences.

The RNA produced by the BI construct should retain the
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ability to splice both of these minimal introns and should produce all three
classes of HIV-1 RNA (unspliced, partially spliced and fully spliced). In
addition, this construct should be capable of producing the Tat and Rev
regulatory proteins. This construct did not contain the RRE, which has
been shown to exhibit CRS activity in some experimental systems
(Brighty and Rosenberg, 1994; Churchill et al., 1996). The RRE was
inserted into the net gene of this construct to generate the construct BIR
(Fig. 1). The presence of the RRE at this site has been previously shown to
function in a similar manner to the normal location of the RRE (Campbell,
Borg, and Arrigo, 1996). Since the BIR construct both produces Rev and
contains the RRE, comparison of the distributions of RNAs produced by
this construct with the distributions of RNAs produced by the BI
construct should provide a good indication of the presence of CRS activity
in the BI construct. The BI and BIR constructs were analyzed by
transient transfection into COS cells. The cells were separated into three
subcellular fractions (Favaro and Arrigo, 1997). RNA was isolated and
analyzed using a quantitative RT-PCR procedure (Arrigo et al., 1989).
The results are shown in figure 2.2. The autoradiographs were
quantitated to determine the ratio of cytoplasmic to nuclear RNA (C:N). A
ratio of 1:1 indicates that 50% of the RNA was found in the cytoplasmic
fractions and 50% was found in the nuclear fraction. In the absence of the
RRE, the unspliced RNA produced by the BI construct had a
predominantly nuclear distribution, as evidenced by a C:N ratio of 0.2:1.
In the presence of the RRE, the unspliced RNA produced by the BIR
construct had a predominantly cytoplasmic distribution, as evidenced by a
C:N ratio of 4.5:1. The fully spliced RNA accumulated predominantly in
the cytoplasm, regardless of the presence or absence of the RRE.

The
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ratios of cytoplasmic to nuclear spliced RNA produced by the BI and BIR
constructs were 20:1 and 16:1, respectively. The difference in the C:N ratio
of unspliced RNA produced by the BI and BIR constructs indicated that
the unspliced RNA produced by the BI construct retained substantial
levels of CRS activity.
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Figure 2.1. Constructs used to localize CRS activity in HIV-1. Schematic
diagram of HIV-l genome, HIV-1 RNAs, and constructs generated. Splice
donors are represented as filled triangles and splice acceptors are
represented as open triangles. Deletions are represented as open boxes.
The filled circle represents the mutated splice donor site. The location of
the RRE in the appropriate constructs is shown. Oligonucleotide primers
used for detection of various RNAs are depicted as arrows above the RNAs.
LDR and aLDR are homologous to sequences in the RNA leader sequence
present in all RNAs. LA8 is just upstream and Gag-Nco is just
downstream of the major 5' splice donor. AA821 is just downstream of the
env splice acceptor. LA23 is just downstream of the 5' tat splice acceptor.
LA45 is just upstream of the major 3' splice donor and LA41 is just
downstream of the 3' tat / rev splice acceptor.
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Figure 2.2. Effect of deletion of the majority of intronic sequences on CRS
activity. Results of RT-PCR analysis, using fractionated RNAs (Cyto 1,
Cyto 2 and Nuclear) from COS cells transfected with 50llg of the indicated
constructs. Cyt01 and Cyto 2 fractions were generated using a buffer
containing 0.05% NP40 and 0.65% NP40, respectively. The remaining
pellet was designated the Nuclear fraction. Detection of unspliced and
fully spliced RNAs is shown. Threefold dilutions of RNA from transfected
cells were assayed to demonstrate the quantitative nature of this
procedure.
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Presence of a minimal intron maintains CRS activity
The unspliced RNA produced by the BI construct contained eRS
activity, although this

constr~ct

was deleted for the majority of HIV-l

intronic sequences. Therefore, we wished to independently examine
constructs containing each of the minimal tat introns for the retention of
CRS activity within the unspliced RNA. To independently examine the
first tat intron, a construct which contained sequences encoding the first
minimal tat intron was generated (FI; Fig. 2.1). This construct was
generated by precisely deleting sequences encoding the second tat intron
from the BI construct, conserving tat and rev reading frames. The FI
construct should produce an unspliced RNA and a spliced RNA encoding
Tat and Rev proteins. The FIR construct was generated through insertion
of an RRE into the nef gene of the FI construct (Fig. 2.1). Both FI and FIR
constructs were transfected into COS cells and assessed by RT-PCR
analysis of fractionated RNAs (Fig. 2.3). In the absence of the RRE, the
unspliced RNA produced by the FI construct had a predominantly nuclear
distribution, as evidenced by a C:N ratio of 0.4: 1. In the presence of the
RRE, the unspliced RNA produced by the FIR construct had a
predominantly cytoplasmic distribution, as evidenced by a C:N ratio of
2.0:1. The fully spliced RNA accumulated predominantly in the cytoplasm,
regardless of the presence or absence of the RRE. The ratios of cytoplasmic
to nuclear spliced RNA produced by the FI and FIR constructs were 4.4: 1
and 3.8:1, respectively. The difference in the C:N ratio of unspliced RNA
produced by the FI and FIR constructs indicated that the
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Figure 2.3. Effect of the first minimal tat intron on CRS activity. Results
of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear,
as in Fig. 2) from COS cells transfected with 50J..1g of the indicated
constructs. Detection of unspliced and fully spliced RNAs is shown.
Threefold dilutions of RNA from transfected cells were assayed to
demonstrate the quantitative nature of this procedure.
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unspliced RNA produced by the FI construct retained substantial levels of
CRS activity.
To independently examine the second tat intron for CRS activity, a
construct containing sequences encoding the second minimal tat intron
was generated (SI; Fig. 2.1). This construct was generated by deletion of
sequences encoding the first tat intron. The SI construct should produce
an unspliced RNA encoding the Tat protein and a spliced RNA encoding
Tat and Rev proteins. The SIR construct was generated through insertion
of an RRE into the nef gene of the SI construct (figure 2.1). Both the SI
and SIR constructs were transfected into COS cells and assessed for CRS
activity by RT-PCR analysis of fractionated RNAs. The results are shown
in figure 2.4. In the absence of the RRE, the unspliced RNA produced by
the SI construct had a predominantly nuclear distribution, as evidenced
by a C:N ratio of 0.8:1. In the presence of the RRE, the unspliced RNA
produced by the SIR construct had a predominantly cytoplasmic
distribution, as evidenced by a C:N ratio of 2.4:1. The fully spliced RNA
accumulated predominantly in the cytoplasm, regardless of the presence
or absence of the RRE.

The ratios of cytoplasmic to nuclear spliced RNA

produced by the SI and SIR constructs were 20:1 and 16:1, respectively.
The difference in the C:N ratio of unspliced RNA produced by the SI and
SIR constructs indicated that the unspliced RNA produced by the SI
construct retained substantial levels of CRS activity.
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Figure 2.4. Effect of the second minimal tat intron on CRS activity.
Results of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and
Nuclear, as in Fig. 2) from COS cells transfected with 50Jlg of the indicated
constructs. Detection of unspliced and fully spliced RNAs is shown.
Threefold dilutions of RNA from transfected cells were assayed to
demonstrate the quantitative nature of this procedure.
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Deletion of utilized splice acceptors does not eliminate CRS
activity
Results had indicated that CRS activity was exhibited by RNAs
containing either minimal tat intron. To further define the sequences
responsible for the CRS activity within RNAs produced by the FI
construct, the SD1 construct was generated. This construct retains the
sequences encoding the 5' splice donor; however, sequences encoding all
known splice acceptor sites have been removed (Fig. 2.1). The SD1
construct should produce only an unspliced RNA; however splicing was
detected in the RNA produced by this construct (see below). The SD1R
construct was generated through insertion of an RRE into the SD1
construct (Fig. 2.1). SD1 and SD1R constructs were transfected into COS
cells and assessed by RT-PCR analysis of fractionated RNAs using
oligonucleotide primers that flanked the splice donor sequences to detect
unspliced RNA. As these constructs do not produce Tat, all transfections
included a Tat-producing plasmid. These constructs also do not produce
Rev; therefore, transfections were performed in the presence or absence of
a Rev-producing plasmid. The results are shown in figure 2.5, upper
panel. The unspliced RNA produced by the SD1 construct, in the absence
of Rev, was found predominantly in the nuclear fraction as evidenced by a
C:N ratio of 0.6:1. The C:N ratio of unspliced RNA produced by the SDI
construct was not affected by the addition of Rev, as evidenced by a C:N
ratio of 0.4:1. In the absence of Rev, the SD1R construct exhibited a
similar RNA profile to that of the SD1 construct, as evidenced by a C:N
ratio of 0.6:1. However, in the presence of Rev, the ratio of cytoplasmic to
nuclear unspliced RNA produced by the SDIR construct was increased to
a ratio of 5.5:1. These results indicated that the SD1R construct,
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containing the major HIV-1 5' splice donor, retained CRS activity within
the unspliced RNA.
Although no known splice acceptor sequences were present within
the SD1R construct, it was still possible that a cryptic spice acceptor
might' have been utilized in conjunction with the 5' splice donor. To
determine whether the splice donor was utilized in the RNA produced by
the SD1R construct, we further examined the RNA produced by this
construct using oligonucleotide primers specific for sequences upstream of
the splice donor to detect total RNA, both spliced and unspliced (Fig. 2.5,
lower panel). In contrast to results using primers that detected only
unspliced RNA, the use of this set of primers indicated that Rev had little
effect on the ratio of cytoplasmic to nuclear RNA produced by the SDIR
construct. In fact, the bulk of the total RNA was found in the cytoplasmic
fractions regardless of the presence or absence of Rev as evidenced by C:N
ratios of 3.6:1 in the presence of Rev and 6.6:1 in the absence of Rev. This
difference in C:N ratio was not seen in other experiments. These results
indicated that the splice donor site within the RNA produced by the SDIR
construct was utilized in combination with a cryptic splice acceptor site(s).
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Figure 2.5. Effect of deletion of known splice acceptors and retention of
the major 5' splice donor on CRS activity. Results of RT-PCR analysis,
using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, as in Fig. 2) from
COS cells transfected with 30J.1g of the indicated constructs. Detection of
unspliced (upper panel) and total (lower panel) RNAs is shown. Threefold
dilutions of RNA from transfected cells were assayed to demonstrate the
quantitative nature of this procedure. All transfections also contained 10
J.1g of a Tat-producing construct. The presence or absence of 10J.1g of a Revprod ucing construct is indicated( + or-).
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To better elucidate the CRS activity present within the unspliced
RNA produced by the SI construct, the SD2R construct was generated.
This construct retains sequences encoding the major 3' HIV-1 splice donor.
Although the sequences encoding the env / nef splice acceptor are retained,
they are positioned upstream of the 3' splice donor. The SD2R construct
should produce only an unspliced RNA encoding Tat; however splicing was
detected in the RNA produced by this construct (see below). The SD2R
construct was transfected into COS cells and assessed by RT-PCR
analysis of fractionated RNAs using oligonucleotide primers that flanked
the splice donor sequences to detect unspliced RNA. As this construct does
not produce Rev, transfections were performed in the presence or absence
of a Rev-producing plasmid. The results are shown in figure 2.6. In the
absence of Rev, the unspliced RNA produced by the SD2R construct had a
C:N ratio of 0.5:1. However, in the presence of the Rev, the ratio of
cytoplasmic to nuclear unspliced RNA was 2.8:1. These results indicated
that the unspliced RNA produced by the SD2R construct retained CRS
activity.
The RNA produced by the SD2R construct was further analyzed
using oligonucleotides directed against sequences upstream of the splice
donor to detect total RNA produced by the construct (Fig. 2.6). In contrast
to results using primers that detected only unspliced RNA, the use of these
primers indicated that Rev had little effect on the distribution of RNA
produced by the SD2R construct as evidenced by C:N ratios of 3.5:1 in the
absence of Rev and 4.4:1 in the absence of Rev. These results indicated
that the splice donor site within the SD2R construct was utilized in
combination with a cryptic splice acceptor site(s).
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Figure 2.6. Effect of deletion of known downstream splice acceptors and
retention of the major 3 r splice donor on CRS activity. Results of RT-PCR
analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear, as in Fig.
2) from COS cells transfected with 25Jlg of the SD2R construct. Detection
of unspliced and total RNAs is shown. Threefold dilutions of RNA from
transfected cells were assayed to demonstrate the quantitative nature of
this procedure. The presence or absence of 25Jlg of a Rev-producing
construct is indicated (+ or - ).
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An isolated splice donor functions as a CRS.
Results obtained using the SD1R and SD2R constructs indicated
that, in both cases, the splice donors were being utilized in conjunction
with cryptic splice acceptors. The NI construct was generated through
deletion of the bulk of sequences between the splice donor and the
polyadenylation signal, leaving only 78 base pairs between these elements.
Due to the lack of sequences downstream of the splice donor, we
anticipated that the RNA produced by the NI construct would be
extremely limited in its utilization of the major 5' splice donor. To
elucidate the role of the major 5' splice donor in the manifestation of CRS
activity, site-directed mutagenesis of this site within the NI construct was
performed. The consensus splice donor sequence within the NI construct
was mutated to generate the NI construct (Fig.2.1). NI and

~NI

constructs

were transfected into COS cells in duplicate. Since these constructs do not
produce Tat, all transfections included a Tat-producing plasmid.
Fractionated RNAs were assessed by RT-PCR analysis using
oligonucleotide primers that flanked the splice donor sequences. The
results are shown in figure 2.7. The unspliced RNA produced by the NI
construct was detected predominantly in the nuclear fraction as evidenced
by a C:N ratio of 0.2:1-0.3:1. Mutation of the splice donor site (ilNI)
resulted in an increase in the ratio of cytoplasmic to nuclear unspliced
RNA as evidenced by a C:N ratio of 1.0:1-1.3:1. These results indicated
that the 5' splice donor was functioning as a CRS within the unspliced
RNA produced by the NI construct. To determine the extent to which the
5' splice donor was utilized, the RNA produced by the NI and ilNI
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constructs was further analyzed using oligonucleotides directed against
sequences upstream of the splice donor to detect total RNA, both spliced
and unspliced (Fig. 2.7). The ratio of cytoplasmic to nuclear total RNA
produced by the NI construct was altered in that the C:N ratio was
increased to 1.0:1-1.5:1. These results indicated that splicing was not
completely eliminated within the RNA produced by the NI construct.
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Figure 2.7. The major 51 HIV-1 splice donor functions as a CRS. Results
of RT-PCR analysis, using fractionated RNAs (Cyto 1, Cyto 2 and Nuclear,
as in Fig. 2) from COS cells transfected with 40J.!g of the indicated
constructs in duplicate. Detection of unspliced and total RNAs is shown.
Threefold dilutions of RNA from transfected cells were assayed to
demonstrate the quantitative nature of this procedure. All transfections
also contained 10 J.!g of a Tat-producing construct.
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Discussion

eRS have been identified throughout the intronic sequences of HIV-1, in

gag, pol, and env (Brighty and Rosenberg, 1994; Cochrane et al., 1991;
Maldarelli, Martin, and Strebel, 1991; Nasioulas et al., 1994; Rosen et al.,
1988; Schwartz, Felber, and Pavlakis, 1992a). In addition, splice sites have
been implicated in HIV-l Rev function (Barksdale and Baker, 1995; Chang
and Sharp, 1989; Hammarskjold et al., 1994; Mikaelian et al., 1996; Tan et

al., 1996). In this report, the CRS activity of HIV-l splice sites was
investigated through sequential mutagenesis of a proviral clone. In the
absence of the majority of HIV-1 intronic sequences, it was observed that
Rev-responsiveness was maintained. It is possible that an important
component of CRS activity was lost through deletion of these intronic
sequences. The intronic sequences may still have a significant impact on
eRS activity within the virus.
Unspliced RNAs containing either the first or second tat intron
exhibited CRS activity. Removal of known splice acceptors did not
eliminate the CRS activity present within the RNAs. These RNAs
contained either the major 5' or 3' HIV-l splice donor site. In the absence
of any known downstream splice acceptors, these splice donors were still
efficiently utilized, in conjunction with cryptic splice acceptors. Deletion
of nearly all sequences between the major 5' HIV-1 splice donor and the
polyadenylation site appeared to reduce, but did not eliminate, the
utilization of the 5' major splice donor. Although deletion of these
sequences did not relieve the eRS activity within the unspliced RNA,
mutation of the splice donor did relieve eRS activity. Therefore, the major
HIV-l 5' splice donor could function as a CRS, even in the absence of
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efficient splicing. These results clearly demonstrated that the HIV-1
splice donor sites are intimately involved in the regulation of the
cytoplasmic accumulation of viral RNA.
The mutation of the splice donor site within i1NI also led to an
apparent decrease in the total level of RNA. This reduction may be due to
a decrease in stability of the RNA caused by the removal of the splice
donor. A similar effect on total RNA levels was previously observed when
the major 3' HIV-1 splice donor was mutated within a subgenomic env
construct (Lu et al., 1990); although the effect seen in the previous report
was more severe and led to an almost complete inability to detect any RNA
produced from the construct.
Results from other groups support the idea that an isolated splice
donor might function as a CRS. Naturally occurring inhibitory 5' splice
sites within the 3' untranslated region of papillomaviruses were shown to
function as CRS in that Rev can counteract their effect (Barksdale and
Baker, 1995). The major 5' splice donor of equine infectious anemia virus
was demonstrated to function as a CRS (Tan et al., 1996). A B-globin splice
donor was shown to be capable of functioning as a CRS (Chang and Sharp,
1989; Hammarskjold et al., 1994; Mikaelian et al., 1996). The HIV-1 tev
splice donor, located within the HIV-1 env gene, also appears to function as
a CRS (Hammarskjold et al., 1994). The results presented in this chapter
indicate that authentic HIV-1 splice donors function as CRS to prevent the
cytoplasmic accumulation of viral RNAs. The identification of utilized
HIV-1 splice donor sites as eRS leaves open the possibility that cryptic
HIV-1 splice donor sites might also function as CRS when expressed
within the appropriate context.
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It seems apparent that the control of HIV-1 RNA production
involves a variety of regulatory activities. Splicing serves to downregulate
the level of cytoplasmic unspliced and partially spliced RNAs. The splice
donors themselves also serve to downregulate the cytoplasmic
accumulation of those RNAs in which they are present. The intronic CRS
may serve to retain RNA in the nucleus, decrease RNA stability, or
decrease RNA cytoplasmic utilization (Brighty and Rosenberg, 1994;
Cochrane et al., 1991; Maldarelli, Martin, and Strebel, 1991; Nasioulas et

al., 1994; Rosen et al., 1988; Schwartz, Felber, and Pavlakis, 1992a). The
combination of each of these regulatory activities may synergize within
the virus to prevent viral structural protein production. Rev may serve to
overcome all of these levels of negative regulation and permit viral
structural protein production.
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Chapter 3

Activation of a Rev-Dependent Cryptic Splice Donor in Human
Immunodeficiency Virus Type-1
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In trod uction
By examining isolated sequences, such as splice sites or intronic
CRS, it is possible to ascribe functions to these elements. However, unless
they are examined together, it is not possible to accurately predict the
interplay of splice sites and intronic CRS that are responsible for the Rev
regulation of viral expression. Much of the work on eRS and Rev
regulation in HIV-1 has been done in disparate systems where relevance of
the results becomes an important criticism. Therefore, it is important to
establish the biological relevance of the isolated phenotype in the context
of a more complete virus. The function of splice sites on Revresponsiveness in the context of a construct that contains intronic eRS
will be examined. It is hoped that this analysis, while more complex, will
provide important insight into the relationship between splice sites and
intronic eRS and outline possible mechanisms of eRS function.
The HIV-1 protein Rev regulates the expression of viral structural
proteins at the level of splicing, transport, stability, and translation
(Arrigo and Chen, 1991; Cochrane et al., 1991; D'Agostino et al., 1992;
Feinberg et al., 1986; Felber et al., 1989; Hadzopoulou et al., 1989;
Hammarskjold et at., 1989; Lawrence et al., 1991; Malim et at., 1988;
Schwartz, Felber, and Pavlakis, 1992b; Sodroski et al., 1986) . Rev performs
this activity by binding to an RNA binding site termed the Rev-responsive
element (RRE) present within the RNAs that it regulates (Hadzopoulou et
al., 1989; Malim et al., 1989b; Rosen et al., 1988). Rev may function by
alteration of the cellular pathway of the RNA (Fischer et al., 1995). Since
Rev is required for protein expression, the Rev dependent RNAs must
contain negative sequences, which Rev overcomes for expression (for
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review see Dayton 1996) (Dayton, 1996). These sequences should not be
present in the Rev-independent tat, rev, and nef genes. These negative
sequences have been termed cis-acting repressor sequences, CRS, and
have been characterized in a variety of experimental systems. Splice sites
have been identified in Rev regulation by several groups (Barksdale and
Baker, 1995; Chang and Sharp, 1989; Hammarskjold et al., 1994;
Mikaelian et al., 1996; Tan et al., 1996). In addition, the isolated major 5'
splice donor of HIV-1 functions as a CRS (Borg, Favaro, and Arrigo, 1997).
Introduction of sequences containing the HIV-1 tat 3' splice donor or splice
acceptor sequences (i.e., those splice sites that join the Tat coding exons)
into a construct containing a B-globin intron conferred Revresponsiveness to the construct (Chang and Sharp, 1989). Revresponsiveness could also be conferred by mutation of the B-globin splice
site consensus sequence within this construct. The CRS potential of splice
donor sequences has been demonstrated by the Rev-responsiveness of
papillomavirus constructs containing a splice donor in the 3' untranslated
region (Barksdale and Baker, 1995). The major 5' splice donor of equine
infectious anemia virus functions as a CRS within EIAV Gag-producing
constructs, although it functions in a location-dependent manner (Tan et

al., 1996). Within HIV-l Env-expressing constructs, splice sites and Ul
interaction have been shown to be important for the regulation of Env
expression by Rev (Lu et al., 1990). Furthermore, the expression of Env
could be made Rev-independent by placing a complete intron upstream of

env and removing known splice donor sequences (Hammarskjold et al.,
1994).
Other sequences within HIV-1, distinct from splice sites, have also
been shown to exhibit CRS activity. Recently, a CRS has been identified
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within HIV-l protease that functions in an orientation independent
fashion to negatively regulate the cytoplasmic accumulation of Rev
dependent RNA (Huffman and Arrigo, 1997). The fusion of various
fragments of the gag, pol, and env genes to a CAT reporter construct
resulted in Rev-responsiveness (Cochrane et al., 1991; Rosen et al., 1988).
The CRS within pol elicited an orientation-dependent 30-fold negative
effect on CAT activity that could be rescued by Rev and the RRE. This
CRS is located within HIV-1 sequences that are not known to contain any
splice sites. The effect appeared to be at the level of mRNA utilization, in
that the subcellular distribution of RNA was not substantially affected.
Other studies have shown that fusion of regions of both gag and pol to
reporter constructs demonstrated at least two orientation-dependent CRS
that functioned posttranscriptionally (Maldarelli, Martin, and Strebel,
1991). These sequences do not contain known splice sites and were not
substantially affected by the addition of splice sites to the constructs.
Fusions of gag to a tat-expression vector were used to analyze CRS activity
within gag (Schwartz, Felber, and Pavlakis, 1992a). Further research on
gag sequences showed that a less than 300 base pair fragment was
capable of exerting an effect on the total RNA production, which was
attributed to differences in RNA stability. Mutational inactivation of this
CRS required 28 point mutations, demonstrating the complex nature of
this CRS (Schwartz et al., 1992). In the absence of known splice sites, env
expression was shown to be Rev-dependent in mammalian cells using Env
expression vectors (Nasioulas et al., 1994). Localization of CRS within env
identified many regions capable of exerting modest negative activity,
which together exerted more dramatic activity. Deletion of the RRE led to
Rev-independent expression of Env from subgenomic env constructs,
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indicating that a CRS may overlap RRE sequences (Brighty and
Rosenberg, 1994; Churchill et

al~,

1996). The complexity of the interaction

between the gag CRS and splicing was recently demonstrated (Mikaelian

et al., 1996). The gag CRS in conjunction with the RRE was capable of
conferring Rev-responsiveness on a B-globin construct. Mutations in
splice sites rendered these constructs Rev-independent. In summation,
these studies indicate that there are several regions that contain CRS,
which determine the viral requirement for Rev.
A potential complication in the study of CRS and the Rev
dependence of viral RNAs is the examination of these sequences in the
context of other CRS. In order to determine the effect of a mutated splice
donor in the context of other viral sequences, the major 5' splice donor was
mutated in the context of gag sequences to determine the impact the
mutation would have on the cytoplasmic accumulation of HIV-1 RNAs.
The ratio of cytoplasmic to nuclear HIV-1 RNAs in the presence or absence
of Rev was analyzed as an indicator of Rev dependence of the RNA. RTPCR was utilized to examine the localization of the RNAs produced by the
transfected constructs. In this chapter, the effect of the major 5' splice
donor, in the context of gag sequences, on the Rev-mediated regulation of
HIV-1 RNAs was examined.

Materials and Methods
Plasmid Constructions
The plasmids CSF and RoSt-A have been previously described (Campbell,
Borg, and Arrigo, 1996; Favaro and Arrigo, 1997). Briefly, CSF is a wild
type infectious proviral clone and RoST-A is a Rev mutant in which Rev is
deleted through the introduction of a stop codon. RoST-A is also deleted for
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a 3600bp pol fragment between the Avr II sites which renders the
construct noninfectious. RoST-A

~SD1

was generated from the RoST-A

construct using DR mutagenesis (Gatlin et al., 1995) and the following
oligonucleotide primers:

~SD1

5'-

AGAACCGCGGACGCCGAAATTTTGACTAGCGGAGGC-3' and

~SD1A,

5'-ACTACCGCGGGTCGCCGCCCCTCGCCTCTTGC-3'. This results in
the deletion of the 5' major splice donor, TGGTGAGT from the RoST-A
construct and the insertion of the sequence CCGCGG.

Cell Culture and Transfection
COS cells were maintained in Iscove's medium supplemented with
10% fetal calf serum. Transfections were performed as described
previously (Arrigo et al., 1989; Borg, Favaro, and Arrigo, 1997). A total of
50 Jlg of plasmid DNA was electroporated for each sample. Cotransfections
were performed with the indicated construct without or without the
addition of 10Jlg pSVtat and/or 10Jlg pCMV Rev (Lewis et al., 1990). A filler
construct (pcDNA3, Invitrogen) was used to normalize the total amount of
DNA to 50Jlg. A confluent T175cm 2 flask of cells was used for
approximately six transfections. RNA was harvested approximately 18
hours post-electroporation.

RNA fractionation and analysis
Cells were fractionated as previously described to obtain two
cytoplasmic and a nuclear fraction (Borg, Favaro, and Arrigo, 1997;
Favaro and Arrigo, 1997). Isolation of RNA and RT-PCR was performed as
previously described (Arrigo and Chen, 1991; Arrigo et al., 1989; Arrigo et
al~,

1990; Borg, Favaro, and Arrigo, 1997). RT-PCR was performed for 20

cycles of amplification for all RNAs except that of the unspliced RNAs
detected with the LA 8 / CSD2 and LA 8/ LA 9 oligonucleotides which
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were amplified for 25 cycles. Most of the oligonucleotide primers used for
detection have been previously described (Arrigo and Chen, 1991; Arrigo et

al., 1989; Arrigo et al., 1990; Borg, Favaro, and Arrigo, 1997). Total RNA
was detected with the LDR/aLDR oligonucleotides. Unspliced RNA was
detected with several different pairs of oligonucleotides including LA 8 and
LA 9, VPR-Xba and LA 23 and LA 8 and CSD2. The antisense
oligonucleotide CSD2 hybridizes downstream of the identified cryptic
splice donor and its sequence is 'CCCACCTATCCAATTCTC'.
Quantitation of the ratio of cytoplasmic to nuclear RNA was done
using a Molecular Dynamics phosphorimager. The cytoplasmic fractions
(Cyto 1 and Cyto 2) were added together and compared to the nuclear
fraction to determine the ratio of cytoplasmic to nuclear RNA. The level of
nuclear RNA was arbitrarily set to a level of 1.

Molecular Cloning and Sequencing of Cryptically Spliced RNA
RT-PCR was performed as described above, on the first cytoplasmic
fraction of RNA from the RoST-A ASDI transfection utilizing the
LA8ILA23 oligonucleotides. This results in amplification of the spliced
RNA. The resulting products were passed over a G50 column (Pharmacia).
The DNA products were then ligated into the plasmid pGEM T-easy
(Promega). The plasmids were then sequenced to determine the location of
the cryptic splice donor. Sequencing of the plasmids was performed using
an ABI 377 DNA sequencer for automated sequence analysis. Fluorescent
dye-:labeled terminators were utilized in conjunction with the T7 primer to
obtain the results.

Results

Mutation of the 5' splice donor of HIV-l does not eliminate
splicing to the downstream splice acceptor
Previous studies have examined RNA expression following
mutation of the major 5' splice donor of HIV-l and found that the splice
site was responsible for Rev dependence when mutated in isolated splice
donor containing constructs (Borg, Favaro, and Arrigo, 1997). One
question raised by these experiments was how the 5' major splice donor
might interact in the more natural context of the HIV-1 genome. In order
to examine this question, the major 5' splice donor was mutated in the
Rev-deleted construct RoSt-A to generate RoSt-A ASD1 (Figurel).

This

mutation deletes the consensus 'gt' required for splicing, as well as a
previously identified cryptic splice donor immediately downstream
(Purcell and Martin, 1993). These constructs are also deleted for pol; to
render them noninfectious. The splice acceptors utilized to produce vif and
vpr RNAs are deleted from these constructs. Transient transfections were
performed in COS cells to assay for the cytoplasmic accumulation of HIV-l
RNA. The RoSt-A and RoSt-A ASDI constructs were transfected in the
presence of Tat and the presence or absence of Rev. A Tat-producing
plasmid was cotransfected to provide a source of Tat for the transfections
with the deletion of the 5' major splice donor. Since neither RoSt-A nor its
derivative RoSt-A ASDI produces Rev, a Rev-producing plasmid or control
plasmid was transfected to assess the effect of Rev on the cytoplasmic
accumulation of RNA. After transfection, RNA was harvested from the
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cells after 18 hours and fractionated into three subcellular fractions. RNA
was isolated and analyzed using quantitative RT-PCR procedure.
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ILTRI

gag
r-,---.
..
pro

vif tat vpu
_c
c:::::::J

pol
I
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LA9

~~
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II
Drev
vpr

..

ILTRI

• c:::::J

nef

...

Vpr-Xba ~

gag/pol

B

T
T
T

tmD

•

tmD

CSF
T

T

RoSt-A
RoSt-AASDl

Figure 3.1. Constructs and oligonucleotides used to identify and examine
Rev regulation of a cryptic splice donor in HIV-l gene expression.
Schematic diagram of HIV-l genome, HIV-l RNAs, and constructs
generated. Section A depicts the viral genome with hypothetical RNAs
produced via splicing. Oligonucleotide primers utilized for detection of
various RNAs are depicted as arrows above the RNAs. LDR and aLDR are
homologous to sequences in the RNA leader sequence present in all RNAs.
LA8 is just upstream and LA9 is just downstream of the major 5' splice
donor. CSD2 is just downstream of the cryptic splice donor. LA23 is just
downstream of the 5' tat splice acceptor. Section B depicts the constructs
(RoSt-A and RoSt-A ASD1) used in these experiments as compared to the
wild type strain CSF. The major 5' HIV-l splice donor is represented as a
filled triangle. Deletions are represented as open boxes. The filled circle
represents the mutated splice donor site. The location of the RRE in the
constructs is shown. The 'T' indicates the addition of a stop codon in RoStA and RoSt-A ASDI that blocks Rev expression.
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Examination of RNA expression utilizing oligonucleotides that
detected all viral RNAs (LDR1/ aLDR1 on Figures 3.1 and 3.2A) indicated
no change in distribution with the presence or absence of Rev or with
mutation of the 5' major HIV-1 splice donor (see Figure 3.2A). The C:N
ratios for the RNA examined with LDRI/ aLDRl were 2.2 and 1.9 for the
RoSt-A (- and + Rev); and 1.6 and 2.5 for the RoSt-A ilSDl (- and + Rev)
respectively. A ratio of 1:1 indicates that 50% of the RNA was found in the
cytoplasmic fractions and 50% was found in the nuclear fraction. The
decreased amount of RNA in the RoSt-A ilSDl plus Rev cytoplasmic
fraction 2 was not reproducible. These results indicate that deletion of the
splice donor resulted in little or no change in the total amount of HIV-l
RNA produced by the constructs.
Examination of RNA expression utilizing oligonucleotides that
detect the unspliced RNA across the 5' HIV-1 splice donor (LA S/ LA9 on
Figures 3.1 and 3.2A) revealed that the RoSt-A construct expressed
cytoplasmic unspliced RNA in a Rev dependent manner. The addition of
Rev was required for the cytoplasmic accumulation of unspliced RNA
produced by the RoSt-A construct. However, the same RNA produced by
the RoSt-A ilSD1 construct appeared Rev independent after mutation of
the splice donor. The C:N ratios for the RNA examined with LAS/ LA
9 were 0.2 and 1.9 for the RoSt-A (- and + Rev); and 1.1 and 1.4 for the
RoSt-A ilSDl (- and + Rev) respectively. A small shift in the size of this
unspliced RNA between the RoSt-A and RoSt-A ilSDl constructs was also
observed. This is due to the loss of two bases with the splice site mutation.
The unspliced RNA at this location was also analyzed utilizing another
pair of oligonucleotides (LA Sand Gag- Nco) and yielded similar results;
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respectively. These results indicated that the RNA produced by the RoStA construct is dependent on Rev for its cytoplasmic accumulation and that
the cytoplasmic accumulation of RNA produced by the RoSt-A dSDl
construct is also dependent on the presence of Rev. Since total RNA
(LDRI/ aLDRl) ratios are similar in the presence and absence of Rev, but
the unspliced (Vpr-Xba and LA 23 and LA 8 and CSD2) are different with
,respect to Rev-dependence; this indicates that splicing activity must be
present in the RoSt-A dSDl construct. This cryptic splice donor must be
located between LA 9 and LA 23. The utilization of this splice donor is also
dependent on the presence of Rev. This is indicated by the fact that Rev
increases the cytoplasmic accumulation of unspliced RNA containing the
cryptic splice donor, while in the absence of Rev, cryptic splicing is
activated (by examination of total RNA ratios).
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Figure 3.2. Identification of cryptic splicing and Rev dependence of RNAs
in the presence and absence of Rev. Results of RT-PCR analysis, using
different pairs of oligonucleotides, of fractionated RNAs (Cyto 1, Cyto 2 and
Nuclear) from COS cells transfected with 30 Jlg of the indicated
constructs. Cyto 1 and Cyto 2 fractions were generated using a buffer
containing ,0.05% NP40 and 0.65% NP40, respectively. The remaining
pellet was designated the Nuclear fraction. Threefold dilutions of RNA
from transfected cells were assayed to demonstrate the quantitative
nature of this procedure. All transfections also contained 10 Jlg of a Tatproducing construct. The presence or absence of 10 Jlg of a Rev-producing
construct is indicated (+ or -). Locations of the oligonucleotide pairs are
listed in Figures 1 and 3.
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Identification of a Cryptic Splice Donor
The oligonucleotide primer set LA B and LA 23 were used to examine
the pattern of spliced RNA and to attempt to identify the cryptic splice
donor. These oligonucleotides will detect products that are spliced from
the 5' major splice donor and downstream of that site to the tat splice
acceptor (see Figure 3.1). Analysis of RNA with LA B and LA 23 indicated
a Rev independent pattern of expression of the spliced RNA. The pattern of
expression of RNA from both the RoSt-A and the RoSt-A i1SD1 constructs
is similar in that neither is dependent on Rev for the cytoplasmic
accumulation of RNA. The spliced RNA produced by the RoSt-A construct
is primarily localized in the first cytoplasmic fraction and its cytoplasmic
accumulation is largely unaffected by the presence or absence of Rev. The
spliced RNA produced by the RoSt-A L1SDI construct is also primarily
cytoplasmic in its distribution and not greatly affected by the
cotransfection of a Rev producing plasmid. Interestingly, there may be a
slight decrease in the level of cytoplasmic spliced RNA in the presence of
Rev. There is a shift in size between the two species of RNA due to the
different location of the splice donor. The cryptic splice donor is located
further downstream of LAB resulting in a larger amplified product.
The spliced RNA from the cytoplasmic 1 fraction of the RoSt-A L1SD1
minus Rev transfection was amplified using the LA B and LA 23 primers
(Figure 3.2B). Subsequently, these products were then cloned into the
pGEM T-easy vector system for sequencing. The plasmids containing the
cloned spliced RNA were then sequenced by an automated ABI 377
sequencer. Sequencing of the cloned RNA with the T7 primer RNA yielded
the location of a cryptic splice donor (Figure 3.3A). The sequencing
identified the splice donor at 793bp in JRCSF as a 5/9 match to the
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consensus sequence (Mount, 1982) This cryptic splice donor lies
immediately downstream of the Gag ATG (Figure 3A). This cryptic splice
donor was utilized with the tat splice acceptor at 5787 bp in JRCSF. The
5/9 match for the identified cryptic site compares to the wild type 5' HIV-1
splice donor which has 8/9 and the 3' major HIV-1 splice donor with 6/9
match to the consensus for splice donors (Figure 3.3B).

A
Purcell Splice Donor
,

Gag ATG
,
_

HIV-1 5' Splice Donor
,

5'

Cryptic Splice Donor

l

3'

GCGCGCACAGCAAGAGGCGAGGGGCGGCG1tTGGTGAGjbCGCCGA~rnTGACTAGCGGAGGCTAGAAGGAGAGAG1fGGGTGCGAbAGCGTCAGTATTAAGCGGGGGAGAATTGGATAGGTGGG
----~.~LAB

1

~---L-A9------

~1~----

CSD2

B

Consensus Splice Donor Site

C AG/GTAAGT
A
G

51 HIV-1 Splice Donor Site

CTG/GTGAGT

3 HIV-1 Splice Donor Site

GCA/GTAAGT

Purcell Cryptic Splice Donor Site

AGAIGTAcGc

Borg Cryptic Splice Donor Site

TGG/GTGcGA

1

Figure 3.3 Sequence ofHIV-1 at the 5' major splice donor and
comparisons of cryptic splice sites. Section A of the figure depicts the DNA
sequence ofHIV-1 JRCSF from 711 bp to 837 bp. The locations of the splice
donors, oligonucleotides and Gag ATG are indicated. The Purcell splice
donor indicates the cryptic splice donor noted by Purcell, et al. Section B of
the figure depicts a comparison of the 5' major splice donor, the 3' major
splice donor, a previously identified cryptic splice donor (Purcell and
Martin, 1993), and the cryptic splice donor identified in this manuscript as
compared to the consensus sequence.
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Discussion
The major 5' splice donor was analyzed, in the context of gag
sequences, in order to determine its role on the Rev-mediated regulation of
HIV-l RNAs. RNAs were analyzed by RT-PCR for cytoplasmic
accumulation with different combinations of oligonucleotides utilized to
assess the localization of different RNAs. The inactivation of the 5' major
splice donor could yield one of three possible effects. First, all splicing
could be eliminated from the RNA produced by the mutated construct.
Second, all other (e.g. the 3' major splice donor) splicing events will
remain but splicing in the 5' intronic region to the tat splice acceptor will
be eliminated. The final possibility is that a cryptic splice donor would be
activated in the 5' region and splicing will also occur in the 3' intronic
region. The data presented in this chapter indicate that the third
possibility is the most probable result of the inactivation of the 5' major
splice donor.
Using a pair of oligonucleotides that hybridize to a region common to
all viral RNAs, total levels of HIV-l RNA were detected (LDRI/ aLDRl). A
similar distribution of RNA was detected in the cellular fractions. Next, a
pair of oligonucleotides that hybridize across the major splice donor was
utilized to detect RNA that is unspliced at that location (LAB and LA 9). In
the presence of the wild-type splice donor, this RNA was unspliced and
required Rev for cytoplasmic accumulation. One caveat is that splicing
may occur downstream of the sequences amplified, hence the PCR product
detected is not necessarily entirely unspliced. When the 5' major splice
donor was deleted in the RoSt-A ilSDl construct this RNA (LAB and LA 9)
is largely independent of Rev for its cytoplasmic accumulation. With
activation of a cryptic splice donor downstream, a shift of the 3'
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oligonucleotide farther downstream (past the cryptic splice donor) again
yields a PCR product that requires Rev for cytoplasmic accumulation (LA
8 and CSD2). Therefore, a cryptic splice site or other CRS element is
present downstream of LA 9. Oligonucleotide pairs were also used to
examine the unspliced RNA across the tat splice acceptor (Vpr-Xba and LA
23). These results when compared to the total RNA levels (LDR1/ aLDR1),
which show equal levels of cytoplasmic accumulation, indicate that
splicing is still occurring to this splice acceptor. The total ratios of RNA
remained unchanged in the presence of Rev, while the unspliced RNA was
dependent on Rev for cytoplasmic accumulation; therefore splicing must
account for the rest of the total RNA. Analysis of the spliced RNA (LA 8
and LA 23) indicated that the spliced products were independent of Rev
and illustrated that a cryptic splice donor was splicing to the tat splice
acceptor site.
The sequence of this site was identified and compared to the
consensus sequence. It is notable that such a poor match (5/9) to the
consensus sequence was utilized as a splice site and regulated by Rev.
However, it is only one basepair less of a match than the 3' major splice
donor of HIV-l. A 5/9 match cryptic splice donor has also been reported
previously in the literature (Purcell and Martin, 1993) (see Figure 3.3).
Presence of this cryptic splice is especially interesting in light of the fact
that there are a large number of possible cryptic sites when gag sequences
were analyzed for consensus matches. Some of these sites are even better
matches than this identified site. There are probably multiple cryptic
sites activated upon mutation of the 5' major splice donor. However, no
other cryptic splicing events were detected by RT-PCR analysis utilizing a
large number of different oligonucleotide pairs throughout gag.
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The fact that Rev regulation requires splice site recognition has
been noted previously (Hammarskjold et al., 1994; Lu et al., 1990). Another
study has reported that a cryptic splice donor is activated upon mutation
of the wild-type splice donor (Purcell and Martin, 1993). The data
presented here demonstrate activation of a cryptic splice donor with the
inactivation of the 5' major splice donor and a previously identified cryptic
splice donor. It was not unexpected that the unspliced RNA expressed
from the RoSt-A ASD1 construct might remain Rev dependent due to the
retention of numerous CRS that have been previously described (for
review see Dayton) (Dayton, 1996) and that splicing might be present
upon activation of cryptic splice donors. However, it is remarkable that
the utilization of this splice donor would be dependent on Rev. In
retrospect, this fact should not be surprising, as others have reported that
suboptimal splice sites appear to be required for Rev regulation of splicing
(Katz, 1990; O'Reilly, McNally, andBeemon, 1995). This is perhaps
because splicing must be inefficient enough for Rev to differentially
regulate the splicing process yet still able to have those sites interact with
cellular splicing factors. The life history of HIV requires that it adapt to
its ever changing genome. Consequently, the observation that a cryptic
splice site immediately downstream of the Gag ATG is regulated by Rev
further confirms the plastic nature of the HIV genome. These studies also
present the possibility that cryptic splice donors may function as CRS in
concert with other identified CRS to determine the Rev-dependence of viral
RNAs.
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Chapter 4

Perspectives
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The question of how splice donors affect the cytoplasmic
accumulation of HIV-l RNAs is part of a much larger discussion of how
cells control the metabolism and expression of RNA. Many of the
difficulties and problems in understanding HIV-l gene regulation result
from our lack of molecular understanding of how cells intrinsically control
these processes. Viruses provide an invaluable tool to probe the cellular
machinery and yield remarkable insight about critical control points in
the complex machinations of gene expression. The findings presented here
add to the understanding of how viruses regulate RNA expression
utilizing cellular processes to control their gene expression.
The finding that an isolated splice donor functions as a CRS raises
several questions. One is, whether splice donors function as a CRS
through splicing or by binding a cellular factor and having an effect
distinct from the splicing reaction. It is obvious that splicing decreases
the amount of unspliced RNA in the cytoplasm. However, it is not clear
that splice donors function as CRS merely through splicing of the RNA.
Indeed the data presented in Chapter 2 support the interesting conclusion
that an isolated splice donor in the presence of minimal splicing functions
as a CRS. Ignoring for a moment the minimal splicing detected in these
experiments, the findings show that a splice donor can function to
negatively regulate the cytoplasmic accumulation of unspliced RNAs. The
molecular event probably involves the binding of cellular factors such as

VI which have been shown to be important in eRS function (Lu et al.,
1990). Binding of VI and other snRNPs must direct the RNA, in the
absence of splicing to a degradative pathway. This must be true since the
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RNA does not accumulate in the cytoplasm nor is it significantly spliced
before transport from the nucleus.
However, minimal splicing was detected in the isolated splice donor
constructs and the possible mechanisms of this splicing are unclear with
the removal of all known splice acceptor sequences and indeed almost all
sequences downstream of the splice donor. Possible mechanisms for this
might include trans or inverse splicing, rare but well described splicing
events (Moore, Query, and Sharp, 1993). Alternatively, readthrough of the
polyadenylation signal may be responsible for generating a larger RNA
that would contain possible 3' cryptic splice acceptor sequences and allow
for splicing. Indeed, readthrough of the polyadenyaltion signal in the 5'
LTR occurs in HIV-1 gene expression, providing a precedent for this
mechanism. In order to investigate these hypotheses we performed 3'
rapid amplification of cDNA ends (RACE) to investigate the sequence of
the spliced RNA but the results were inconclusive.
Another interesting question raised by the findings in Chapter 2 is
the difference in function between the two major splice donors of HIV-1.
The ratios indicate that the second major splice donor is much less of a
CRS than the 5' splice donor. It also is 3bp less of a match to the
consensus sequence. It might seem probable that the degree of consensus
sequence might function to determine the "strength" of a CRS. This might
be true because an increase in binding of cellular factors to the CRS could
increase the negative regulatory function of the CRS. The binding of
splicing factors RNAs has been shown to retain RNAs in the nucleus
(Stutz and Rosbash, 1994). It is important to remember that splicing must
be regulated for the production of the different classes of viral RNA. In
order for this regulation to occur, splicing of viral mRNA must be
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inherently inefficient. If splice sites yield efficient splicing, then the
reaction would be completed and it would be impossible to rescue unspliced
RNA. The finding that an isolated splice donor can regulate the fate of an
RNA, without splicing is novel and interesting. How does this relate back
to wild-type viral expression? The next set of experiments was designed to
investigate that question.
Experiments in Chapter 3 address questions of splice donor function
in the context of gag sequences. It is difficult to assess the impact of a
particular CRS, such as the 5' major splice donor of HIV-l, in the context
of other CRS. Mutation of one CRS does not eliminate negative regulation
of the RNA because of the redundancy of these elements. These
experiments identified a cryptic splice donor that is Rev-responsive. These
findings raise several questions including- why do cryptic sites appear
upon inactivation of wild-type sites? The answer is not readily apparent
but several hypotheses are possible. One explanation for the presence of
multiple cryptic sites is the presence of Rev. Since Rev is present during
the expression of unspliced RNA to rescue the RNA there is no negative
selection for the presence of cryptic elements. Indeed, with significant
mutation rates in HIV-1 there maybe some selective pressure to maintain
cryptic sequences so that the unspliced RNAs might remain Rev
dependent even with a mutation of the wild-type splice donor. The reason
for the redundancy of CRS function may never be known but it is curious
to speculate on possible reasons for this feature of HIV-l gene regulation.
Another interesting finding from Chapter 3 was the location of the
cryptic splice donor that was identified. It is the next possible site
downstream of the previous cryptic splice donor (Purcell and Martin,
1993) which is immediately downstream of the wild type site. It is perhaps
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significant that cryptic site selection appears to proceed 5' to 3' through
the RNA. Also supporting this is the observation that several better
possible cryptic sites exist in gag but do not appear to be utilized for
cryptic splicing.
These data suggest that all CRS might be splice sites or splice sitebinding elements. In support of this are the large number of possible
cryptic sites that exist throughout HIV-1. Perhaps the intronic CRS
discussed previously are merely sequences (or structures) that bind
snRNPs and retain the unspliced RNA in the nucleus. Many of the
identified CRS have been examined for splice sites and found to contain
none but this does not rule out this mechanism of function. A consensus
match may not be required for the binding of a particular factor that in
association with a number of other proteins retain the unspliced RNAs in
the nucleus. Such a mechanism would be extremely difficult to test, but
might be a likely explanation of CRS function.
One piece of evidence that might help evaluate this hypothesis is the
finding of a CRS in protease that functions in an orientation independent
manner and negatively regulated the cytoplasmic accumulation of RNA
(Huffman and Arrigo, 1997). These sequences were examined for splicing
events and none were detected. However, sequence analysis suggests that
possible cryptic sites might exist. This may indicate that splicing was not
present, but could also mean that snRNPs could still be bound to the RNA
that retain the CRS containing RNA in the nucleus. Another note is that
this sequence appears much weaker than the splice site CRS, which in
addition to the orientation effect, is in support of a different mechanism of
function. In light of this and other evidence it is difficult to assess the
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nature of intronic CRS and whether they are cryptic splice sites or cryptic
splice site binding elements.

73

8
-----II

RREe

I--~

REV
o~

0

II-

~

0

~

~

0

0

~o

0

0

0

~

0
~

Figure 4.1 This is a hypothetical model of Rev function and its
interaction with viral RNAs. The outside boundary is a cell membrane
and the large oval structure represents the nucleus. The binding of Rev to
various RNAs is depicted as are some of the feedback loops involved in Rev
regulation of viral RNA expression.

In light of these findings, a potential model of Rev function is shown
in Figure 4.1. This figure shows the expression of Rev from the fully
spliced RNA. This RNA is translated to produce Rev, which is localized to
the nucleus via its NLS. Once in the nucleus Rev binds to the Rev
response element located in Env. The binding of Rev then allows for
rescue of the Rev-dependent RNA. Previous work has defined the role of
the Rev response element (RRE) in HIV-1 gene regulation. The location of
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the RRE has an important impact on RNA expression (Campbell, Borg,
and Arrigo, 1996).
The binding of Rev "rescues" the Rev-dependent unspliced and
partially spliced RNAs for expression. Rev may also decrease its own
expression while increasing the expression of Rev-dependent RNAs.
Whether Rev actually decreases splicing, and thereby production of Rev,
or whether Rev merely increases the export of the Rev dependent RNAs is
uncertain. Popular belief holds that export explains the observed decrease
in Rev expression but other data seems to suggest this may not be entirely
true. Recent work has shown that Rev can function to inhibit splicing
(Favaro and Arrigo, 1997). This work also showed that differences in cell
type change the cellular requirement for Rev. While Cos cells absolutely
require Rev for cytoplasmic accumulation of RNA, T cells have a low level
of cytoplasmic accumulation in the absence of Rev (Arrigo and Chen, 1991;
Favaro and Arrigo, 1997). Rev then facilitates the cytoplasmic
accumulation of unspliced and partially spliced RNAs but also has further
effects on the fate of the RNA.
In the cytoplasm, Rev may also have critical effects on the
regulation of RNA expression. Rev may have an important effect on
translation of the Rev-dependent RNAs. This is supported by the
observation that Rev is not absolutely required for cytoplasmic
accumulation of Rev-dependent RNAs in the absence of Rev in lymphoid
cells, whereas no expression of proteins occurs in the absence of Rev
(Arrigo and Chen, 1991; Favaro and Arrigo, 1997). This level of control
may involve association of the RNA with poly-A binding protein (PAB1).

PABI binds to polyadenylated RNAs and facilitates 60s ribosomal subunit
binding. In the absence of Rev, the Rev-dependent RNAs are defective in
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their association with PAB1 (Campbell et al., 1994). This level of
regulation may explain the lack of translation of these RNAs.
Rev then has an impressive series of functions for a 19Kd protein.
After binding to the RRE, Rev may function in splicing, export, stability
and translation of the Rev-dependent RNAs as well as regulating its own
production. How does Rev accomplish all of this? One theory is that Rev
merely directs the RNA to different cellular pathways. By associating
with a number of different cellular factors, it might influence the
processing by the cellular machinery. In so doing, Rev appears to have
many effects. This is especially true when you consider the many different
systems used to analyze Rev function. As systems are different, the
primary effect of Rev on the fate of the RNA may appear different.
Interestingly, the ideas that were originally controversial are now
becoming more accepted. The dominant export paradigm of Rev function is
still questioned. This is not to say that Rev does not regulate export,
merely that other effects are also critical functions of Rev in the regulation
of RNA expression.
In the regulation of gene expression, splice sites are critical features
that direct RNA metabolism. HIV-1 utilizes the features of this processing
to variably regulate the production of different RNAs from a single
primary transcript. By using splice sites to control the expression of
unspliced RNA, HIV-1 controls the temporal expression of the viral genes.
The story of HIV-1 gene regulation is a complex tapestry of interwoven
regulatory systems that not only provide important clues to
understanding cellular gene expression but also contains the knowledge
required to treat and prevent the Acquired Immune Deficiency Syndrome.
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